Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Journal of Cancer Research and Clinical Oncology|December 23, 2025
Impact of comorbidities on treatment management and prognosis in patients with anaplastic thyroid cancer (ATC)Teresa Augustin, Dmytro Oliinyk, Marlen Haderlein, et al.
Frontiers in Immunology|February 18, 2026
Sex-specific differences in abscopal responses to combined radiotherapy and immune checkpoint inhibition-insights from a multicenter studyMaike Trommer, Alexander Rühle, Felix Ehret, et al.
Radiation Oncology (London, England)|May 20, 2026
Outcome of patients with lung cancer treated with stereotactic body radiotherapy for bone oligometastases - a European multicenter cohort studySebastian Schäfer, Isabell Seiler, Panagiotis Balermpas, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 6, 2025
Outcome Prediction in Older Adults With Head and Neck Cancer Undergoing ChemoradiationSebastian N Marschner, Elia Lombardo, Erik Haehl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 12, 2025
Short-course radiotherapy versus long-course chemoradiotherapy in total neoadjuvant therapy of rectal cancer - A multicenter analysis of early outcomes and toxicityGeorg Wurschi, Miriam Kesselmeier, Melanie Schneider, et al.
Clinical and Translational Radiation Oncology|March 19, 2026
Stereotactic body radiotherapy in patients with bone oligometastases from breast cancer - results from a European multicenter cohort studySebastian Schäfer, Isabell Seiler, Lena Kästner, et al.
International Journal of Cancer|February 18, 2026
Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of lifeGeorg W Wurschi, Andreas Hinz, Melanie Schneider, et al.
Clinical and Translational Radiation Oncology|February 18, 2026
Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysisGeorg W Wurschi, Melanie Schneider, Jan-Niklas Becker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapySimon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 10, 2025
Impact of target volume and dose concepts on the outcomes of prostate cancer patients treated with stereotactic body radiotherapy for spinal metastases - a European multicenter cohort studyIsabell Seiler, Sebastian Schäfer, Camilla von Wachter, et al.
Pageof 12